Too Much of a Good Thing or Not Enough? Treating Scleroderma With ILD and PH: A Pro-Con Debate

Session Format

Pre-Recorded

Session Type

Clinical Controversy

Topic Area

ILD and Friends

Description

Current guidelines advise treatment for pulmonary arterial hypertension (PAH) but not interstitial lung disease- (ILD-) associated pulmonary hypertension. Patients with scleroderma often present with both, and while targeted therapy may improve PAH, it may be harmful in ILD, and the optimal treatment strategy is unclear. Using a Pro-Con debate format, this session fulfills the needs of cardiac and pulmonary practitioners in reviewing the management of patients with mixed PAH and ILD. At the conclusion of this session, participants will appreciate the risks and benefits in treating these patients, and be able to apply this knowledge to their own clinical practice.

Learning Objective 1

Review the epidemiology, natural history, and treatment options of scleroderma-PAH.

Learning Objective 2

Review the epidemiology, natural history, and treatment options of scleroderma-ILD.

Summary


Availability:	On-Demand


Cost:	FREE


Credit Offered:	1 CME Credit